GlassScriptPhysician profile
Ghasem Imani
NPI 1609307966
$4,275.30
in general payments reported to CMS, 2019-2025
19 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $158 · 2023: $129 · 2024: $2,674 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,373 · Travel and Lodging: $1,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.72 |
| Travel and Lodging | $1,745.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,449.07 | 2022-2025 | Lithovue, General - Kidney Stone Disease, Ams 700 Cxr Rte Kit |
| Procept Biorobotics Corporation | $527.54 | 2024-2025 | Aquabeam System |
| Calyxo, INC. | $230.77 | 2025 | Cvac Aspiration System |
| Conmed Corporation | $192.57 | 2024 | |
| Endo USA, INC. | $161.09 | 2024-2025 | Xiaflex, Aveed |
| Angiodynamics, INC. | $144.80 | 2024 | Nanoknife |
| Laborie Medical Technologies Corp. | $105.86 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $96.55 | 2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $64.78 | 2024-2025 | |
| Abbvie INC. | $60.23 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $57.17 | 2023-2024 | Pylarify |
| Urogen Pharma, INC. | $35.43 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $34.03 | 2024 | Provenge |
| Novo Nordisk INC | $28.04 | 2024 | Rivfloza |
| Photocure INC | $24.97 | 2025 | Cysview |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $18.00 | 2023 | Illuccix |
| Astellas Pharma US INC | $15.84 | 2023 | Myrbetriq |
| Hollister Incorporated | $15.61 | 2023 | Infyna Chic |
| Rti Surgical, INC | $12.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghasem Imani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.